Condition
CMV Infection clinical trials and research
As of November 12, 2026, Find a Trial lists 4 CMV Infection clinical trials that are recruiting, at sites in 9 countries (most in South Korea (2), Belgium (1), France (1)). By phase: Phase 1/2 (1), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 9Countries
Newest CMV Infection clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Virus-specific T cells for kids after stem cell transplant | — | Seoul | Recruiting | Jul 6, 2026 |
| Multi-Virus Specific T cells for antiviral-resistant CMV, BKV, or EBV after cancer therapy or stem cell transplant | Phase 1/2 | Seoul | Recruiting | Jun 26, 2026 |
| Artesunate combined with standard antiviral therapy for CMV in organ transplant recipients. | Phase 2 | Boston, Massachusetts and 3 other locations | Recruiting | Feb 28, 2025 |
| T-cell therapy for viral infections after stem cell transplant | Phase 3 | Brussels and 32 other locations | Recruiting | Apr 6, 2021 |
All recruiting trials (4)
-
Virus-specific T cells for kids after stem cell transplant
This trial tests whether giving virus-specific T cells can safely help children with CMV, EBV, or BKV infections after a stem cell transplant.
-
Multi-Virus Specific T cells for antiviral-resistant CMV, BKV, or EBV after cancer therapy or stem cell transplant
This trial tests LB-DTK-MV cells to see if they safely reduce CMV, BKV, or EBV in patients who have antiviral-resistant infections after cancer treatment or stem cell transplant.
-
Artesunate combined with standard antiviral therapy for CMV in organ transplant recipients.
This trial will try adding IV artesunate to standard ganciclovir or oral valganciclovir in adult solid organ transplant patients with CMV to see if it improves viral clearance and safety.
-
T-cell therapy for viral infections after stem cell transplant
This study is testing whether giving special T-cells that target specific viruses can help patients who have had a stem cell transplant and are struggling with tough viral infections.
Related topics
Quick answers
How many CMV Infection clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in South Korea (2 trials), Belgium (1 trial), France (1 trial), Germany (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.